三基改性阴性体通过稳定多离子复合增强体内mRNA输送
Jumpei Norimatsu1, Hayato L Mizuno2, Takayoshi Watanabe1
1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan. horacio@g.ecc.u-tokyo.ac.jp.
Materials horizons
|July 11, 2024
概括
三 (TPP) 为信使RNA (mRNA) 纳米载体提供了一种新的非氨基离子. 基于TPP的细胞增强了mRNA传递和蛋白质生产,克服了先进的mRNA疗法的传统氨基载体的局限性.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 阴离子纳米载体对于信使RNA (mRNA) 疗法至关重要.
- 传统的氨基基基载体在稳定性和交付效率方面面临挑战.
- 探索非氨基酸酸替代品对于改善mRNA疗法至关重要.
研究的目的:
- 引入trifenylphosphonium (TPP) 作为mRNA纳米载体的非氨基离子部分.
- 研究TPP替代对纳米载体特性和mRNA输送的影响.
- 评估基于TPP的纳米载体在mRNA输送方面的治疗潜力.
主要方法:
- 修改含氨酸的聚合物以纳入TPP.
- 创建用于mRNA封装的聚合物微粒.
- 纳米载体的物理化学,热力学和计算分析.
- 在静脉注射后对mRNA生物可用性和蛋白质生产的体内评估.
主要成果:
- 替代TPP显著改变了聚合物的自我组装和mRNA结合.
- 与氨基基基对应物相比,基于TPP的聚合物微粒表现出增强的稳定性.
- 携带TPP的小胞体在固体瘤中显示了mRNA生物可用性增加和高效的蛋白质生产.
- TPP已经成为mRNA输送系统的有前途的替代性cationic组.
结论:
- 三 (TPP) 是一个可行的和有利的替代传统的氨基在mRNA纳米载体.
- 基于TPP的聚合物微粒提供了更好的稳定性和增强的体内mRNA输送.
- 这项研究为开发使用TPP修饰的纳米载体的下一代mRNA疗法提供了坚实的基础.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


